Hauser SL, Kappos L, Montalban X, Craveiro L, et al. Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis. Neurology 2021 Sep 2. pii: WNL.0000000000012700.
PMID: 34475123